Abstract
Objectives
Poor quality sleep, including sleep fragmentation (SF), can result in severe health consequences. Gut microbiota symbiotically coexist with the host, making essential contributions to overall well-being. In this study, the effects of both acute (6-day) and chronic (6-week) SF in a humanized rat model were examined to evaluate the impact of SF on this symbiotic relationship.
Material and Methods
Human fecal material was transplanted into antibiotic-treated, microbially depleted, Sprague Dawley rats. Animals were subjected to either acute or chronic SF and shifts to gut microbiota were investigated using 16S rRNA sequencing and predictive functional profiles were constructed with PICRUSt. We also investigated SF-induced intestinal microbial adhesion and penetration or increased microbial invasion of selected tissues and organs; as well as changes in crypt/villi architecture.
Results
Microbiota profiling indicated that chronic, but not acute, SF significantly decreased the richness of alpha-diversity of distal ileum microbiota, and altered cecum and distal ileum beta-diversity; although both acute and chronic SF significantly changed select populations of microbiota in all three regions. Neither acute nor chronic SF induced changes to microbial adhesion, penetration, or invasion into intestinal tissues or nearby organs. Additionally, we found that chronic SF caused a reduction in villus height in the proximal colon.
Discussion
Our study suggests that acute SF alters the gut microbiota in this humanized rat model, while chronic SF produces more pronounced changes to microbiota populations. This study identified potential microbiota targets for the prevention and/or intervention of the adverse effects of S F.
Keywords: Sleep Fragmentation, Sleep Disturbances, Gut Microbiota, Humanized Rat Model, Metagenomics, 16S rRNA
INTRODUCTION
Consistent, quality sleep is vital to peak performance. Disrupted sleep not only leads to impaired physical function, mood, and cognition, but also induces stress that may alter the structure and function of gut microbiota communities, creating dysbiosis, a disequilibrium of commensal gut microbes1,2,3,4,5,6,7,8,9,10. For example, mice subjected to a brief period (5h) of sleep deprivation led to altered abundance of Clostridiaceae and Lachnospiraceae compared to controls2, while a longer period (5 days) of sleep disruption resulted in an increased Firmicutes:Bacteroidetes ratio, along with decreased abundance of Lactobacillus, Actinobacteria, and Bifidobacterium9. Rats undergoing 8h of sleep fragmentation for 28 days however showed a lower Firmicutes:Bacteroidetes ratio, with a reduced abundance of putative short chain fatty acid-producing bacteria and higher Proteobacteria8. By sampling the gut microbiota from different regions of the intestinal tract after acute and chronic sleep fragmentation treatments, we identified temporal and region-specific changes in rats in our previous study10. There were significant perturbations in the alpha- and beta-diversity, especially in the distal ileum, with several taxa (including Lachnospiraceae, Lactobacillaceae, Ruminococcaceae, Prevotella, and Turicibacteraceae, among others) showing altered abundancies in multiple regions after either/both acute and chronic treatments. Similar to the result of Bowers et al. (2020)9, human subjects showed an increased Firmicutes:Bacteroidetes ratio after two days of partial sleep deprivation7, with changes in the abundances of the Coriobacteriaceae, Erysipelotrichaceae, and Tenericutes.
Dysbiosis of gut microbiota can significantly impact host systems, such as metabolism and immune response, which can lead to degraded host physiology and health4,5,6. To illustrate this complex relationship, in a study of nine, healthy men, just two nights of partial sleep deprivation led to decreased insulin sensitivity, a decreased presence of beneficial microbiota, and an altered gut microbiota composition specifically associated with obesity and type 2 diabetes7. Further, sleep fragmentation (SF), or repeatedly interrupted sleep without a reduction in total sleep time, which commonly occurs in disorders like sleep apnea, restless leg syndrome or chronic pain, has also been reported to alter microbiota populations and negatively affect health8,9,10. And in older adults where SF is more common, links between poor sleep, altered gut microbiome composition and age-related cognitive decline as seen in neurodegenerative conditions such as Alzheimer’s or Parkinson’s have been reported11.
Bidirectional communication between the gut microbiota and the brain, often referred to as the microbiome-gut-brain axis, is thought to be a key regulator of human health, as gut microbiota can interact directly or indirectly with the nervous, endocrine, metabolic, and immune systems12,13. This gut microbiota-host signaling is vital to maintain healthy function, and dysfunction of this communication is believed to be an important contributing factor in many diseases14. Therefore, prebiotic- and/or probiotic-based manipulation of this symbiotic ecosystem may hold great potential for uncovering preventive and/or therapeutic intervention strategies.
Previous studies examining the effects of various sleep disturbances upon gut microbiota have generated mixed results. While most showed that irregular sleep leads to stress-induced microbiota dysbiosis in humans and animals, several studies reported limited perturbations of gut microbiota7,15,16,17. These differences may be due to dissimilarities in type of sleep disturbance, time points of sample collections, and/or methodologies used to generate and analyze experimental data. Human subjects, in particular, present challenges in microbiome studies as obtaining region-specific microbiota samples and histological examination of tissues are excessively invasive. One way to address these difficulties involves utilization of animal models harboring solely human gut microbiota via fecal transplant (i.e., ‘humanized’ models that are devoid of native gut microbiota). Multiple humanized models have been developed, each with its own advantages and disadvantages18,19,20. While we and other investigators have previously reported dysbiosis of gut microbiota in rats under sleep fragmentation8,10, it is not clear if these findings are relevant to humans under the same situation, since humans and rats have very different gut microbiota profiles.
In an effort towards obtaining human-relatable data as to the effect of sleep fragmentation (SF) upon gut microbiota, we conducted both acute (6-day) and chronic (6-week) SF experiments in rats harboring the human gut microbiota from multiple human donors. Intestinal content was collected from three gastrointestinal tract locations (distal ileum, cecum, and proximal colon) following acute or chronic SF, and 16S rRNA gene sequencing performed to identify significant changes in microbiota populations. The functional impact of these changes was inferred using the software tool, PICRUSt. Further, we determined whether SF encouraged intestinal bacterial translocation by evaluating microbial adhesion, penetration, and invasion of surrounding tissues. Finally, we inspected architectural changes in the intestinal crypt/villi of the corresponding regions of the gastrointestinal tract used in microbiota analysis.
MATERIAL AND METHODS
Ethics statement
This study protocol was reviewed and sanctioned by the Wright-Patterson Air Force Base Institute of Research, Institutional Animal Care and Use Committee (IACUC), and the U.S. Air Force Surgeon General’s Office of Research Oversight and Compliance. All experiments were performed in compliance with the animal welfare act. All experiments were in compliance with the principles set forth in the “guide for the care and use of laboratory animals”21. All work was performed in an Association for the Assessment and Accreditation of Laboratory Animal Care (AAALAC) - accredited facility.
Methods
Animals: Sprague Dawley (SD) rats (specific pathogen free) were acquired from Charles River (2-week old, Wilmington, MA, USA). Initially, all rats were housed in standard, clear plastic cages (2 animals per container) with standard bedding (CellZorb, Cincinnati Lab Supply). Rats had ad libitum access to food (LabDiet Formulab Diet 5008, Cincinnati Lab Supply) and water. Rats, when housed in semi-rigid isolators (Charles River), were singly held in sterile cages containing sterile bedding (Alpha Dri Irradiated Bedding, Charles River) located in a germ-free room. Sterile food (Picolab Rodent Irradiated Chow, Charles River) and water was provided ad libitum. Rats were maintained in a 12h light/dark cycle at 22°C.
Fecal transplantation into microbially depleted rats: the gut microbiota of SD rats was humanized as described previously22. Briefly, animals were segregated into semi-rigid isolators (Charles River) and exposed to a 12-day antibiotic treatment (enrofoxacin 200mg/L, neomycin 800mg/mL, and vancomycin 850mg/L), prepared fresh daily in the drinking water. Agar culture of fecal and cecal contents and gel electrophoresis of bacterial 16s rRNA PCR products (collected from antibiotic-treated rats) were examined to ensure that gut microbiota were significantly knocked down prior to fecal transplant. Identical amounts of human fecal material from 5 donors, supplied by OpenBiome (Somerville, MA), were homogenized, mixed in Luria broth (total colony forming unit of 2.04E+09), and introduced to the intestinal tracts of the rats by oral gavage. Animals were inoculated with the human fecal mixture at five time points, on days 1, 3, 5, 8, and 11 (day 1 = the first fecal inoculation), and SF experiments began 2 weeks after the final inoculation. This current study utilized fecal samples from 5 of the 6 donors listed in the previous animal model development study as one subject was excluded from this study due to insufficient fecal material22.
Sleep fragmentation: naïve and humanized rats were individually housed in sleep fragmentation chambers (Lafayette Instrument Company; Lafayette, IN; model No. 80391) where a bar swept horizontally across the cage foor, as described previously by Ramesh et al. (2009)23. While this procedure significantly reduced both slow wave sleep and rapid eye movement sleep in mice (based on EEG measurements), it is relatively stress-free in that no increase in the serum level of corticosterone or body temperature was detected in the treated animals23. This moving obstacle would awaken the rat, as the rat had to step over the sweeper bar. In the acute SF study, the bar swept across the cage bottom every 3min for 6 days. For the 6-week period of the chronic SF study, the sweeper bar remained stationary for 3 hours each day (12 p.m. to 3 p.m.) for safety reasons, as this longer study would be more strenuous for the animals. The control group (normal sleep) were also housed in the SF chambers under identical conditions, with the exception that the sweeper bar was immobile.
Sample acquisition, DNA isolation, and library preparation: after 6 days or 6 weeks of SF, animals were asphyxiated by CO2. The liver, spleen, and intestinal material (from the distal ileum, cecum, and proximal colon) were harvested, and tissues from the intestinal walls, mesentery, and mesenteric lymph nodes were collected. All samples were fash frozen in liquid nitrogen, and stored at -80°C, with the exception of the intestinal tissues, which were placed on ice for immediate investigation into bacterial adhesion, penetration and invasion (see below). QIAamp DNA Stool Mini Kit (Qiagen) was utilized to isolate DNA from 250mg of intestinal material. DNA was quantified with a NanoDrop ND-1000 Spectrophotomer (Fisher Scientific). The Ion 16S Metagenomics kit (Fisher Scientific) was used for DNA library preparation for the Ion Torrent system. This kit amplifies a wide range of variable DNA regions, including: V2, V3, V4, V67, V8, and V9 (data from all variable regions were used in OTU identification). Agencourt AMPure XP magnetic beads (Fisher Scientific) were used for DNA purification and an Agilent 4200 TapeStation (D1000) was used for quantification. Ion Plus Fragment Library Kit (Fisher Scientific) was used for DNA end repair and ligation of adapters to 50ng of DNA, which was then labeled with Ion Xpress Barcode Adapters 1-96 Kit (Fisher Scientific).
DNA sequencing and taxonomic analysis: sample DNA were pooled and loaded onto 530 chips (Life Technologies) using the Ion Torrent Ion Chef System (Life Technologies). DNA was sequenced on an Ion Torrent S5. DNA processing and quality filtering (Q<10, 400 base pairs) was automated using Ion Torrent Software (Suite v.5.2). Quantitative Insight into Microbial Ecology (QIIME2, v.2018.11) was used to analyse FASTQ files24. DNA (250 base pairs) were filtered with a Phred Quality score of 2025,26. GreenGenes reference database (v.13.8, 99% sequence identity) was used to assign operational taxonomic units (OTUs)27. Alpha diversity was evaluated using Faith’s phylogenetic diversity index and the Kruskal-Wallis test (p<0.05); while beta-diversity profiles were gaged by weighted normalized UniFrac and Bray-Curtis methodologies (PERMANOVA, p<0.05, 999 permutations) and visualized with Emperor software28,29,30. Perturbations to individual microbiota populations were evaluated using Gneiss balance correlation clustering (Ward’s hierarchical methodology)31. This analysis does not directly compare relative abundance between taxa as that information is likely biased due to limitations in PCR amplicon production and the compositional nature of sequencing data, which reports abundance in a relative manner. Instead, Gneiss analyses the relative, differential abundance of taxons to characterize niche differentiation.
PICRUSt analysis: microbial community functionality was assessed using Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt, v.1.1.3)32. OTUs were assigned by 97% sequence identity using a closed reference search against GreenGenes database (v.13.5). OTU tables were normalized and referenced against the Kyoto Encyclopedia of Genes and Genomes (KEGG) Orthology (KO) database. Predictive PICRUSt data were analyzed for statistical significance using Statistical Analysis of Taxonomic and Functional Profiles (STAMP, v.2.1.3) and White’s non-parametric t-test with Benjamini-Hochberg FDR post hoc test33.
Bacterial adhesion, penetration, and invasion: analysis of bacterial adhesion, penetration, and invasion was performed as described previously10. Briefly, non-adhered microbial cells were collected from intestinal tissue after a 15min gentle shake with 1mM dithiothreitol in PBS. Adhered microbial cells were isolated after 60 seconds of vigorous vortexing of the tissue with PBS. Penetrated microbial cells were recovered from the washed tissues after homogenization with PBS in a Bullet Blender Gold (Next Advance). Cells were pelleted and stored in 15% glycerol in lysogeny broth. Microbial titers (from adhesion and penetration isolation, intestinal content or homogenized organ tissue) were determined by aerobic and anaerobic culturing on 5% sheep blood agar plates with TSA (Fisher Scientific, ran in duplicate). BD GasPak EZ Gas Generating System (Fisher Scientific) was use in the culturing of anaerobic bacterial colonies and a Scan 300 Automatic Colony Counter (Interscience) tallied colony expansion to calculate colony-forming units (CFU) per gram of tissue/material.
Hematoxylin and eosin staining of intestinal tissue: sliced intestinal tissues (12µm thickness) were fixed to gelcoated microscope slides, and stained with hematoxylin and eosin. Topical features were measured using a Leica microscope (Leica Microsystems CMS GmbH, Leica Application Suite X, v.3.3.3.16958). Only villi that had a clearly defined luminal epithelial surface and submucosal muscle layer were measured. Similarly, only crypts with an easily visible submucosa cell layer and crypt wall inward pinch were measured. For statistical analysis, the mean value of each set of measurements was used (2-way ANOVA, Tukey’s and Sidak’s multiple comparison).
General lab equipment and chemicals, unless otherwise specified above, were purchased from Fisher Scientific.
RESULTS
Metagenomic profiles of humanization
Native gut microbiota of naïve Sprague Dawley rats were decimated prior to human fecal transplant, as previously implemented by our lab22. The stool samples from 15 naïve Sprague Dawley rats were collected before and after humanization and analyzed along with fecal material from the 5 human donors. Relative abundance and diversity of microbiota from rats and human donors was evaluated with 16S metagenomic analysis. Figure 1A compares alpha-diversity (Faith’s phylogenetic diversity metric) and illustrates the richness and diversity of the fecal microbiota before antibiotic treatment and humanization is significantly different from both the human and humanized samples (Kruskal-Wallis, pairwise, p=0.0018 and p=0.0020, respectively). Notably, the alpha-diversity of fecal microbiota is not significantly different between the samples from human donors and humanized rats. Beta-diversity between microbiota communities was evaluated using Bray-Curtis dissimilarity index and visualized by PCoA plot (Figure 1B). Significant dissimilarities can be easily discerned between the rat baseline/humanized and baseline/human samples (PERMANOVA, 999 permutations, p<0.001), while microbiota profiles of the human and humanized samples are more alike as they form a data cluster that can be easily separated from the rat baseline samples.
Figure 1.

Humanization of rat gut microbiota. Both the (A) alpha-diversity (Faith’s phylogenetic diversity index) and (B) beta-diversity (weighted-normalized-Unifrac) of fecal bacterial communities of human donors and of Sprague Dawley rats before and after humanization, showing that the humanization of the gut significantly shifts the native rat microbiota profile toward the human counterpart.
Table 1 lists the relative frequency of the detected phyla, where Bacteroidetes and Firmicutes accounted for 94%-95% of all identified phyla in rat, human and humanized rat samples. When comparing the naïve rat to the humanized rat, there was a significant decrease (p=0.001) in Firmicute populations. In the lesser phyla, humanization resulted in a significant reduction (p=0.029) of Tenericutes, and a downward trend in Verrucomicrobia and Deferribacteres populations (p=0.066 and p=0.91, respectively). The humanization process also resulted in a significant increase (p=0.002) in Proteobacteria, that surpassed human levels. This aberrant increase in Proteobacteria was also observed in our previous humanized model development study22. Additionally, Actinobacteria populations failed to expand closer to human levels even though Actinobacteria was detectable in the Sprague Dawley native microbiota Fusobacteria, which was present in only one of the human donor samples, was not established within the humanized rat.
Table 1.
Average relative proportion (with standard deviation) of phyla detected in the fecal material of naïve Sprague Dawley rats (rat baseline), humanized rats (post-humanization baseline) and human donors. Significant changes between phyla of naïve rats and humanized rats were established by t-test (p<0.05).
| Human | Rat baseline | Humanized rat | p-value | |
|---|---|---|---|---|
| Bacteroidetes | 54.86%±7.28 | 51.02%±10.53 | 61.21%±5.82 | 0.291 |
| Firmicutes | 40.48%±8.58 | 44.52%±11.20 | 32.49%±6.27 | 0.001 |
| Proteobacteria | 2.91%±1.64 | 1.46%±0.94 | 6.14%±1.90 | 0.002 |
| Actinobacteria | 0.89%±0.73 | 0.04%±0.04 | 0.04%±0.05 | 0.395 |
| Deferribacteres | 0.00%±0.00 | 0.26%±0.05 | 0.02%±0.08 | 0.091 |
| Tenericutes | 0.01%±0.01 | 2.21%±2.44 | 0.00%±0.01 | 0.029 |
| Verrucomicrobia | 0.00%±0.00 | 0.45%±0.62 | 0.09%±0.14 | 0.066 |
| Cyanobacteria | 0.00%±0.00 | 0.04%±0.06 | 0.01%±0.03 | 0.125 |
| Fusobacteria | 0.86%±1.65 | 0.00%±0.00 | 0.00%±0.00 | --- |
Phylogenetic profling of microbiota populations following sleep fragmentation
Humanized rats were exposed to SF for either 6 days or 6 weeks, and gut microbiota communities were collected from the distal ileum, cecum and proximal colon for 16S rRNA analysis. Ion Torrent sequencing of the 136 samples collected after SF (acute: 10 SF subjects and 14 normal sleep subjects, with 23 distal ileum, 24 cecum, and 24 proximal colon samples collected; chronic: 11 SF subjects and 11 normal sleep subjects with 22 distal ileum, 22 cecum, and 21 distal ileum samples collected) resulted in 50,028,527 high-quality 250-bp single-end reads. A total of 8,249 and 8,053 features were identified in the acute and chronic SF analysis of 16S rRNA. Supplementary Figure 1 displays the rarefaction analysis (Faith’s phylogenetic index) for both acute and chronic SF studies. As noted in previous studies10,34, phylogenetic abundance and diversity in the distal ileum is reduced compared to microbiota populations of the cecum and proximal colon. However, a distinct separation of data is not evident in the acute study. This suggests that the humanization process may have encouraged an initial overgrowth of the transplanted microbiota in the small intestine. A similar change was observed in the small intestine following humanization in our previous study22. Based upon the results of this rarefaction analysis, alpha- and beta-diversity was profiled at a depth of 30,000 reads for maximum sample retention.
Alpha and beta diversity are altered after acute and chronic sleep fragmentation
Alterations to alpha-diversity richness in microbiota populations of the distal ileum, cecum and proximal colon after acute or chronic SF are shown in Figure 2. Following 6 days of SF, there were no statistically significant fuctuations in microbiota richness in any of the three intestinal regions (AC). However, a 6-week period of SF leads to a striking trend of decreased alpha-diversity in all sampled communities (DF), with a significantly diminished richness (Kruskal-Wallis (pairwise), p=0.0039) in the microbiota of the distal ileum (D).
Figure 2.

Altered alpha-diversity in microbiota of the distal ileum (A and D), cecum (B and E), or proximal colon (C and F), of humanized rats following acute (A, B, and C) or chronic (D, E, and F) sleep fragmentation (Faith’s phylogenetic diversity, Kruskal-Wallis).
Changes in beta-diversity due to SF were measured using the weighted normalized Unifrac method. The result, visualized with PCoA plots (Figure 3), shows that chronic SF significantly altered beta-diversity in the distal ileum (PERMANOVA, p=0.039) and in the cecum (p=0.035), but not in the proximal colon. In contrast, acute SF did not result in a significant shift to beta-diversity in any region, although changes to cecal microbiota populations approached significance (p=0.081).
Figure 3.

Chronic sleep fragmentation alters microbiota profiles. Beta diversity was measured using the weighted normalized Unifrac method and illustrated by PCoA plots. Significant alteration occurred in the distal ileum and cecum under chronic sleep fragmentation. The percent diversity captured (PC) by each axis is shown.
Altered microbiota populations due to acute and chronic sleep fragmentation
Gneiss balance profiling was used to identify significant changes to microbiota populations with acute or chronic SF compared to controls, and the results are presented in Figure 4. Gneiss detects abundance differentiation in microbial niches and infers changes in microbial subcommunities. The results showed multiple high-level balances, or shifts, in microbial niche communities. For example, in the distal ileum, acute SF (panel A) led to decreases vs. controls in multiple members of Lactobacillus (here, the genus is listed 5 separate times as the program was able to recognize, but not fully identify, species-level classifications). Also in the distal ileum, acute SF led to increases in Firmicutes and Coprococcus. Chronic SF (panel B) resulted in decreases vs. controls in the Lactobacillales, Turicibacter, and several members of Enterobacteriaceae, while multiple Turicibacter members expanded. In the cecum, acute SF (panel C) caused reductions in Ruminococcus, Succinivibrio and Bacteroides, and growth in the Bacteroidales and the Firmicutes, as compared to controls. Chronic SF (panel D) also resulted in reduced Bacteroides, Enterobacteriaceae, and Lachnospiraceae, while expansions occurred in Ruminococcaceae and multiple Clostridiales members, and Lachnospiraceae in the cecum when compared to controls.
Figure 4.

Gneiss balance profiles of microbiota alternation of humanized rats following sleep fragmentation. Listed are the top ten increased and decreased in microbial taxa in the distal ileum (A and B), cecum (C and D) and proximal colon (E and F) following either acute (A, C, and E) or chronic (B, D, and F) sleep fragmentation.
The largest microbiota population changes in the proximal colon due to acute SF (panel E) include decreases vs. controls in multiple members of Oscillospira and increased vs. controls in Firmicutes, Rikenellaceae, and multiple Clostridiales members. Interestingly, Lachnospiraceae populations both expanded and contracted. This same pattern of Lachnospiraceae expansion and contraction was also observed in the proximal colon with chronic SF (panel F). In addition, multiple members of Clostridiales were increased, while Bacteroides and Rikenellaceae were reduced vs. controls after chronic SF.
Prediction of metagenomic functions with PICRUSt analysis
PICRUSt and STAMP analyses were performed to infer functional consequences of SF-induced alterations to gut microbiota. Across all 3 intestinal regions in both the acute and chronic studies, 60 unique metabolic pathways were significantly (p<0.05) affected by SF-induced microbiota dysbiosis, with 7 pathways being altered under multiple conditions/in multiple regions. The majority of these pathways can be broadly classified into 10 functional categories (including nucleotide metabolism, DNA replication, repair & recombination, transcription & RNA processing, translation & protein processing, regulation of organismal systems, and metabolism of amino acids, carbohydrates, energy, lipids, terpenoids, polyketides, and xenobiotics). Most of these pathway changes were the result of perturbed microbial communities in the cecum, with 11 and 28 altered pathways identified in the acute and chronic SF studies, respectively. Table 2 summarizes the result of pathway alterations in each functional category following acute and chronic SF in each intestinal region.
Table 2.
Summary of significant changes in the microbiota functions inferred by PICRUSt analysis. Listed are the numbers of significantly altered pathways in various functional categories due to microbiota dysbiosis in the distal ileum, cecum, and proximal colon of humanized rats after acute or chronic sleep fragmentation.
| Acute | Chronic | All | ||||||
|---|---|---|---|---|---|---|---|---|
| Distal ileum | Cecum | Proximal colon | Distal ileum | Cecum | Proximal colon | Acute | Chronic | |
| Carbohydrate & energy metabolism | 0 | 1 | 0 | 1 | 4 | 1 | 1 | 6 |
| Lipid metabolism | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 2 |
| Nucleotide metabolism | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 |
| DNA replication, repair & recombination | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 6 |
| Transcription & RNA processing | 2 | 0 | 1 | 1 | 1 | 1 | 3 | 3 |
| Amino acid metabolism | 0 | 1 | 0 | 0 | 2 | 0 | 1 | 2 |
| Translation & protein processing | 1 | 2 | 0 | 0 | 5 | 0 | 3 | 5 |
| Xenobiotics metabolism & degradation | 1 | 1 | 0 | 0 | 0 | 1 | 2 | 1 |
| Terpenoids & polyketides metabolism | 0 | 3 | 2 | 2 | 3 | 1 | 5 | 6 |
| Organismal systems | 1 | 1 | 2 | 1 | 2 | 2 | 4 | 5 |
| Organismal systems (cellular) | 1 | 1 | 3 | 0 | 4 | 0 | 5 | 4 |
| All | 7 | 11 | 8 | 6 | 28 | 7 | 26 | 41 |
Of these functional categories, terpenoids and polyketides metabolism, organismal systems and organismal systems (cellular) contain the most pathway changes. Interestingly, the numbers of pathways affected by acute and chronic SF in most functional categories are very similar, with three exceptions, carbohydrate and energy metabolism, DNA replication, repair and recombination, and translation and protein processing (highlighted), whose perturbation mainly occurred in the cecum after chronic SF. Acute and chronic SF seem to target specific pathways concerning host functions; for instance, acute SF mainly affected the immune system in all three intestinal regions investigated, while chronic SF affected the excretory, endocrine, and nervous systems in a region-specific manner. The entire list of altered pathways in the distal ileum, cecum, and proximal colon following acute or chronic SF are shown in Supplementary Table 1.
Consequences of sleep fragmentation upon microbial adhesion, penetration, and invasion
To determine if SF altered the capacity for bacteria to adhere and penetrate intestinal mucosal barriers or to undergo extraintestinal invasion of the mesentery, lymph nodes, spleen and liver, aerobic and anaerobic bacteria were cultured from these tissues. The results of the testing indicated that microbial invasion, adhesion, or penetration did not occur in any of the organs or intestinal regions tested (data not shown).
Sleep fragmentation alters intestinal architecture
SF-induced changes to intestinal structures were assessed by measuring the length, width and number of crypts and villi, as well as the ratio of crypt to villi. No significant structural changes were observed in the distal ileum, cecum, or proximal colon for the acute study. However, chronic SF resulted in a significant decrease (p=0.021) in villus height in the proximal colon (318.9±35.4µm vs. 275.1±47.5µm), but not in the distal ileum (normal sleep=420.0±62.6µm; SF=431.1±73.0µm) or cecum (normal sleep=238.2±35.1µm; SF=255.0±33.5µm). On the other hand, the treatment did not cause significant change in the number of villi, crypt depth or crypt width in any intestinal location. Occludin staining analysis of intestinal tissues also did not show significant difference between normal sleep and SF samples (data not shown), suggesting that tight junction integrity was not affected by acute or chronic SF.
DISCUSSION
Acute and chronic sleep fragmentation studies were conducted on Sprague Dawley rats harboring gut microbiota obtained from multiple human donors with diverse microbiota. A humanized model was necessitated, as fecal samples alone are not representative of the regional characteristics of gut microbiota; and utilization of the humanized model allowed for analysis of the contents and tissue samples in the intestinal regions and organs of interest in a coordinated manner, which ethically would not be feasible in human subjects. In this study, humanization of intestinal microbiota was accomplished in antibiotic-treated germ-free rats via repeated inoculations of human fecal material, a method successfully employed by ourselves and other investigators22,35,36.
Our approach in the development of this humanized model, which used fecal material sourced from multiple donors during fecal transplant, aided in creating a more complete and representative spectrum of human microbiota. Further, this approach can effectively eliminate donor-specific varieties, a confounding factor commonly associated with humanized rodent models; our “de-individualized” model will be extremely useful for mechanistic analysis of human gut microbiota modulation and the impact to the host systems.
The resulting humanized gut microbiota was distinctly more human-like than the pre-existing, native rodent gut microbiota, as evident by the results of the 16S rRNA gene sequencing and characterization. Perhaps not surprisingly, there was not a complete reconstitution of the human donor fecal microbiota, as antibiotic treatment does not completely (or permanently) eradicate all native rodent microbiota. Additionally, rat and human genetics, diet, and digestive tract physiologies are simply quite different. Furthermore, it is believed that human immune cells may play a role in microbiota stability and engraftment, and their functions might not be completely fulfilled by the rodent counterpart37. Interestingly, decimation of gut microbiota populations including Tenericutes, Verrucomicrobia, Deferribacteres, and Cyanobacteria, which was observed in rats post-humanization in this study, have generally been associated with overall improved health and positive effects. Conversely, the expansion of Proteobacteria is potentially worrisome as this abundant phylum is comprised of several known human pathogens and many species are associated with inflammation38,39,40. Despite the imperfect establishment of the human microbiota, our humanized rat model recapitulated gut microbiota that was substantially similar to the microbiota of the human fecal donors, as illustrated by the alpha- and beta-diversity studies.
Our data indicate that gut microbiota dysbiosis occurs after just 6 days of SF in humanized rats; and with chronic SF, aberrations to microbial populations increased. Acute SF tended to decrease the richness of alpha-diversity, though the changes were not statistically significant. Chronic SF resulted in a more drastic decline in the richness of microbiota in all three intestinal regions investigated, which reached statistical significance in distal ileum. In addition, chronic SF significantly shifted the beta-diversity of both the distal ileum and the cecum. Multiple taxa of gut microbiota were significantly altered with both acute and chronic SF. In a previous study of fecal pellets by Poroyko et al. (2016)16, sleep disruption in mice led to expansion of Firmicutes, Lachnospiraceae, Ruminococcaceae, and Clostridiales, while Lactobacillaceae populations contracted. Some of these changes (e.g., increases in Oscillospira and Ruminococcus of Ruminococcaceae) were also detected in a study of sleep-deprived rats using the ‘flowerpot’ method (which reduces REM sleep only), in addition to the changes in several other taxa (Akkermansia, Parabacteroides, Phascolarctobacterium, and Aggregatibacter)41. Similarly, the effect of SF treatment mirrored these trends in the study reported here. Specifically, acute SF resulted in increased Firmicutes in all three intestinal regions sampled.
Firmicutes are involved in energy resorption, and expansion of this phylum has been linked with obesity, low-grade inflammation, and subsequent development of chronic diseases42,43,44. One particular order of Firmicutes and Clostridiales was increased in both the cecum and proximal colon after SF. While some species of Clostridiales have been connected with overall mental health, other species are pathogenic and are associated with severe diarrhea, bowel diseases, and Parkinson’s disease45,46,47. Overgrowth of Lachnospiraceae, which occurred in the proximal colon after both acute and chronic SF, as well as in the cecum with chronic SF, is reportedly involved in intestinal inflammation and metabolic dysfunction48,49. In contrast, Lactobacillus, a genus of Lactobacillaceae, is well-recognized as beneficial lactic acid bacteria. Lactobacillus, which was decreased in distal ileum after SF in this study, exhibits a mutualistic relationship with humans, as it protects the host against potential invasions by pathogens. In fact, Lactobacillus is among the most commonly used probiotics that can maintain and/or improve human health. Interestingly, most of these changes were also observed in our previous study using native Sprague Dawley rats under the same experimental conditions10, although the models used in these two studies harboring gut microbiota of different origins, i.e., rat vs. human.
Detailed inspection of the results revealed that several taxa showed concordant changes; these include Enterobacteriaceae (decreased in distal ileum after chronic SF), Ruminococcaceae (increased in cecum after chronic SF), Lachnospiraceae (decreased in proximal colon after acute SF), and Bacteroides (decreased in proximal colon after chronic SF). Related taxa (at different taxonomic levels) showing the same change directions in response to SF were also detected, including Lactobacillales/Lactobacillaceae/Lactobacillus (decreased in distal ileum after acute and chronic SF), Turicibacteraceae/Turicibacter (increased in distal ileum after chronic SF), Bacteroidales/Bacteroides (increased in cecum after acute SF), and Clostridiales/Clostridiaceae/Clostridium (increased in cecum and proximal colon after chronic SF). As these changes frequently induced by SF in different models, they likely represent common targets of and/or common response to SF. Since SF results in changes in both beneficial (e.g., Lactobacillus, Ruminococcaceae, and Bacteroides) and pathogenic (Lachnospiraceae, Enterobacter, and Clostridium) taxa, understanding the functional impacts of these changes in an integrated manner will be essential for the intervention of the adverse effects of this stressor.
One caveat to note in this study is that while the age of the rats was the same at the beginning of SF (aged 13 weeks) by the end of the experiment the rats were of different ages (acute 14 weeks vs. chronic 19 weeks). This age difference may have had an impact on the microbiota present at the time of sampling. An alternative approach is to start SF late in the acute experiment so that the animals in the two experiments would be the same age at sample collection. However, this alternative merely changes the nature of the problem – an age difference at the start of SF treatment.
To obtain a clearer picture of how these SF-induced alterations to microbiota might affect the host, the functional impact of these changes was inferred using PICRUSt and STAMP analysis. Unsurprisingly, multiple metabolic pathways were altered, including metabolism of polyketides. Further, both acute and chronic SF led to significant decreases in the fundamental processes of transcription and translation. Alarmingly, chronic SF resulted in a diminished capacity for DNA repair, replication, and recombination. DNA repair, in particular, is vital for genome integrity, normal function, and ultimately, longevity and health. In fact, multiple genes initially associated with increased life span turned out to be involved in the repair of damaged DNA50. Comparison of this pathway list with that of our previous study10 revealed that SF induced unique changes in the humanized rat model, affecting the overall transcription and RNA processing activity of the gut microbiota, as well as the pathways essential for host functions, including glutamatergic synaptic transmission, cardiac muscle contraction, renin-angiotensin system, bicarbonate reclamation, and water absorption (vasopressin regulated). In contrast, pathways related to bacterial toxin synthesis and secretion that were activated in the native Sprague Dawley rats after SF10 were not detected in this study. Further targeted studies will be needed to verify these predictions and evaluate their biological significance and implications.
The mucosal barrier of the intestinal walls controls translocation of intestinal contents, protecting the rest of the body from exposure to pathogenic microorganisms and other toxins51. Previous studies have shown that total sleep deprivation increases bacterial translocation from the intestine to surrounding tissues and organs15,52. However, in this current study, SF did not change the ability of microbiota to adhere to or penetrate intestinal tissues, nor did it induce extraintestinal microbial invasion of the mesentery, lymph nodes, spleen, or liver. This result suggests that the gut does not become leaky even after the 6-week SF treatment employed in this study, which is consistent with that of our previous study10. This finding is further supported by the outcome of the occludin staining experiment that showed no significant changes in this protein, which suggests that the tight junction structure of the intestinal tract is relatively intact.
The intestines are highly specialized to acquire energy, serving as the main pathway of mineral and nutrient absorption. In addition, the intestines are also essential for metabolism, drug uptake, and immune response53,54. Intestinal walls are covered in self-renewing crypt-villi structures, which increase the absorptive surface area of the intestine and provide a quick response to physiological needs55. In the acute SF study, histological staining revealed no significant changes to intestinal architecture. However, chronic SF resulted in a significant decrease in villus height in the proximal colon, a morphological change suggestive of intestinal inflammation and villous atrophy that is associated with a variety of gastrointestinal problems.
There are several limitations in this study. For instance, the sleep architecture of the rats was not monitored during the SF treatments. Consequently, it would be difficult (if not impossible) to correlate the gut microbiota changes with the overall degree of sleep fragmentation, or with specific changes in different sleep stages. Despite this, the SF procedure employed in this study is highly effective. Ramesh et al. (2009)23 reported that this procedure significantly reduced both slow wave sleep and rapid eye movement sleep, based on EEG measurements. Furthermore, the treated animals also showed a significant decrease in wakefulness in the following dark (wakeful) period, with a significant increase in delta power of the EEG measurements. Considering the complexity of the humanization procedure, we reasoned that performing EEG measurements in these animals (which requires surgery) would likely introducing confounding factors in the data, which could be detrimental to the entire study.
We are also aware that the Greengenes database has not been updated since 2013. Thus, the taxonomic assignment of the features may not be up-to-date (e.g., many features in the Gneiss analysis are classified only at the level of bacteria). Furthermore, our data analysis pipeline could be further refined, which may produce a result with deeper insight into SF-associated gut microbiota change and its potential effect on the host.
In summary, both acute and chronic SF led to alterations in gut microbial populations and their collective effects on gut microbiota and host functions; and prolonged SF further resulted in increased microbiota dysbiosis and alterations to intestinal crypt/villi architecture. These findings provide insights into potential targets for preventive and/or therapeutic approaches aimed to maintain symbiotic homeostasis when confronted by the stress of disrupted sleep. Furthermore, the humanized model as described here will be useful for generating new knowledge concerning region-specific perturbation of gut microbiota that is highly relevant to human microbiome and health research.
ACKNOWLEDGMENT
The authors appreciate the technical assistance of Chelsey Webb, Victoria Hutzley, Dominique Brown, Joshua Bevins, Timothy Bausman, Jo Griffin, Heather Procopio, Curtis Schimmel, Katherine Ingram, Eric Perez, Amanda Short, Kirt Henderson, Amy Walters, Steve Sayson, Emily Hill, and Leah Shurte. This research was supported in part by an appointment to the Postgraduate Research Participation Program at the U.S. Air Force Research Laboratory, administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and USAFRL. Data can be requested by contacting the corresponding author. Cleared for public release 25 August 2020 (case number: 88ABW-2020-2651).
Appendix 1.
Supplementary Figure 1.

Rarefaction analysis of Sprague Dawley rats and humanized rats. Rarefaction analysis assessing species richness (Faith’s phylogenetic diversity) across all samples from (A) acute and (B) chronic sleep fragmentation studies.
Appendix 2.
Supplementary Table 1.
Significant differences in the functional metagenome of microbiota predicted by PICRUSt analysis. List of all significantly altered metabolic pathways due to microbiota dysbiosis in the distal ileum, cecum, and proximal colon of humanized rats undergoing either acute or chronic sleep fragmentation. Seven pathways were affected by both acute and chronic SF and/or in multiple intestinal regions. White’s non-parametric t-test with Benjamini-Hochberg FDR post hoc test was used in determining statistical significance (p<0.05).
| KEGG pathway | Sleep fragmentation | Intestinal region | p-value | Change in mean proportions (%) | |
|---|---|---|---|---|---|
| A | Carbohydrate & energy metabolism | ||||
| 1 | Glycolysis / Gluconeogenesis | Acute | Cecum | 0.033 | -0.0250 |
| 2 | Ascorbate and aldarate metabolism | Chronic | Distal Ileum | 0.015 | -0.0220 |
| 3 | Carbohydrate metabolism | Chronic | Cecum | 0.014 | 0.0210 |
| 4 | Carbon fixation pathways in prokaryotes | Chronic | Cecum | 0.044 | -0.0520 |
| 5 | Citrate cycle | Chronic | Cecum | 0.043 | -0.0830 |
| 6 | Oxidative phosphorylation | Chronic | Cecum | 0.023 | -0.1370 |
| 7 | Inositol phosphate metabolism | Chronic | Proximal colon | 0.039 | -0.0070 |
| B | Lipid metabolism | ||||
| 8 | Lipid biosynthesis proteins | Acute | Cecum | 0.042 | -0.0200 |
| 9 | Steroid biosynthesis | Chronic | Distal ileum | 0.049 | 0.0001 |
| 10 | Linoleic acid metabolism | Chronic | Proximal colon | 0.042 | -0.0050 |
| C | Nucleotide metabolism | ||||
| 1 | Purine metabolism | Acute | Distal ileum | 0.042 | -0.1880 |
| 2 | Pyrimidine metabolism | Chronic | Cecum | 0.012 | -0.0600 |
| D | DNA replication, repair & recombination | ||||
| 1 | DNA replication proteins | Chronic | Cecum | 0.015 | -0.0510 |
| 2 | DNA replication | Chronic | Cecum | 0.011 | -0.0330 |
| 3 | DNA repair and recombination proteins | Chronic | Cecum | 0.007 | -0.1030 |
| 4 | Mismatch repair | Chronic | Cecum | 0.042 | -0.0270 |
| 5 | Nucleotide excision repair | Chronic | Cecum | 0.014 | -0.0150 |
| 6 | Homologous recombination | Chronic | Cecum | 0.024 | -0.0400 |
| E | Transcription & RNA processing | ||||
| 1 | RNA polymerase | Acute | Distal ileum | 0.048 | -0.0230 |
| 2 | Transcription related proteins | Acute | Distal ileum | 0.050 | -0.0120 |
| 3 | Transcription machinery | Acute | Proximal colon | 0.004 | -0.0310 |
| 4 | RNA degradation | Chronic | Distal ileum | 0.030 | 0.0110 |
| 5 | RNA polymerase | Chronic | Cecum | 0.019 | -0.0170 |
| 6 | RNA polymerase | Chronic | Proximal colon | 0.021 | -0.0110 |
| F | Amino acid metabolism | ||||
| 1 | Tyrosine metabolism | Acute | Cecum | 0.021 | -0.0130 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis | Chronic | Cecum | 0.032 | 0.0240 |
| 3 | Amino acid related enzymes | Chronic | Cecum | 0.009 | -0.0450 |
| G | Translation & protein processing | ||||
| 1 | Glycosyltransferases | Acute | Distal ileum | 0.027 | -0.0520 |
| 2 | Ribosome biogenesis in eukaryotes | Acute | Cecum | 0.028 | -0.0020 |
| 3 | Protein processing in endoplasmic reticulum | Acute | Cecum | 0.037 | -0.0060 |
| 4 | Ribosome | Chronic | Cecum | 0.008 | -0.1500 |
| 5 | Ribosome biogenesis in eukaryotes | Chronic | Cecum | 0.042 | -0.0020 |
| 6 | Translation factors | Chronic | Cecum | 0.011 | -0.0270 |
| 7 | Protein export | Chronic | Cecum | 0.027 | -0.0490 |
| 8 | Peptidoglycan biosynthesis | Chronic | Cecum | 0.026 | -0.0270 |
| H | Xenobiotics metabolism & degradation | ||||
| 1 | Drug metabolism - other enzymes | Acute | Distal ileum | 0.040 | 0.0110 |
| 2 | Atrazine degradation | Acute | Cecum | 0.034 | 0.0080 |
| 3 | Bisphenol degradation | Chronic | Proximal colon | 0.049 | -0.0060 |
| I | Terpenoids & polyketides (& secondary metabolites) metabolism | ||||
| 1 | Geraniol degradation | Acute | Cecum | 0.049 | -0.0040 |
| 2 | Flavonoid biosynthesis | Acute | Cecum | 0.035 | 0.0030 |
| 3 | D-Arginine and D-ornithine metabolism | Acute | Cecum | 0.033 | 0.0030 |
| 4 | Biosynthesis of type II polyketide products | Acute | Proximal colon | 0.031 | -0.0001 |
| 5 | Indole alkaloid biosynthesis | Acute | Proximal colon | 0.016 | -0.0001 |
| 6 | Carotenoid biosynthesis | Chronic | Distal ileum | 0.039 | 0.0010 |
| 7 | Tetracycline biosynthesis | Chronic | Distal ileum | 0.013 | 0.0110 |
| 8 | Prenyltransferases | Chronic | Cecum | 0.039 | -0.0270 |
| 9 | Terpenoid backbone biosynthesis | Chronic | Cecum | 0.016 | -0.0310 |
| 10 | Zeatin biosynthesis | Chronic | Cecum | 0.025 | -0.0050 |
| 11 | Vitamin B6 metabolism | Chronic | Proximal colon | 0.040 | 0.0080 |
| J | Organismal systems | ||||
| 1 | RIG-I-like receptor signaling pathway | Acute | Distal ileum | 0.015 | -0.0020 |
| 2 | NOD-like receptor signaling pathway | Acute | Cecum | 0.048 | -0.0020 |
| 3 | Bacterial invasion of epithelial cells | Acute | Proximal colon | 0.038 | -0.0001 |
| 4 | Cardiac muscle contraction | Acute | Proximal colon | 0.039 | -0.0010 |
| 5 | Vasopressin-regulated water reabsorption | Chronic | Distal ileum | 0.026 | 0.0001 |
| 6 | Glutamatergic synapse | Chronic | Cecum | 0.050 | -0.0070 |
| 7 | Cardiac muscle contraction | Chronic | Cecum | 0.015 | -0.0130 |
| 8 | Renin-angiotensin system | Chronic | Proximal colon | 0.020 | 0.0001 |
| 9 | Proximal tubule bicarbonate reclamation | Chronic | Proximal colon | 0.009 | 0.0040 |
| K | Organismal systems (cellular) | ||||
| 1 | Apoptosis | Acute | Distal ileum | 0.048 | -0.0060 |
| 2 | Phosphatidylinositol signaling system | Acute | Cecum | 0.033 | -0.0040 |
| 3 | Notch signaling pathway | Acute | Proximal colon | 0.031 | -0.0001 |
| 4 | Wnt signaling pathway | Acute | Proximal colon | 0.031 | -0.0001 |
| 5 | p53 signaling pathway | Acute | Proximal colon | 0.049 | -0.0001 |
| 6 | Phosphatidylinositol signaling system | Chronic | Cecum | 0.046 | -0.0090 |
| 7 | Apoptosis | Chronic | Cecum | 0.017 | -0.0040 |
| 8 | p53 signaling pathway | Chronic | Cecum | 0.014 | -0.0040 |
| 9 | Cell cycle – Caulobacter | Chronic | Cecum | 0.018 | -0.0260 |
REFERENCES
- 1.Lo JC, Groeger JA, Santhi N, Arbon EL, Lazar AS, Hasan S, et al. Effects of partial and acute total sleep deprivation on performance across cognitive domains, individuals and circadian phase. PLoS One. 2012;7(9):e45987. doi: 10.1371/journal.pone.0045987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.El Aidy S, Bolsius YG, Raven F, Havekes R. A brief period of sleep deprivation leads to subtle changes in mouse gut microbiota. J Sleep Res. 2020;29:e12920. doi: 10.1111/jsr.12920. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Parekh PJ, Oldfield EC, Johnson DA. The effects of sleep on the commensal microbiota. J Clin Gastroenterol. 2018 Mar;52(3):204–209. doi: 10.1097/MCG.0000000000000965. [DOI] [PubMed] [Google Scholar]
- 4.Reutrakul S, Van Cauter E. Sleep infuences on obesity, insulin resistance, and risk of type 2 diabetes. Metabolism. 2018 Jun;84:56–66. doi: 10.1016/j.metabol.2018.02.010. [DOI] [PubMed] [Google Scholar]
- 5.Ivanov II, Honda K. Intestinal commensal microbes as immune modulators. Cell Host Microbe. 2012 Oct;12(4):496–508. doi: 10.1016/j.chom.2012.09.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Belkaid Y, Hand T. Role of the microbiota in immunity and inflammation. Cell. 2014 Mar;157(1):121–141. doi: 10.1016/j.cell.2014.03.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Benedict C, Vogel H, Jonas W, Woting A, Blaut M, Schumann A, et al. Gut microbiota and glucometabolic alterations in response to recurrent partial sleep deprivation in normal-weight young individuals. Mol Metab. 2016 Oct;5(12):1175–1186. doi: 10.1016/j.molmet.2016.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Maki KA, Burke LA, Calik M W, Watanabe-Chailland M, Sweeney D, Ronick-Rosendale LE, et al. Sleep fragmentation increases blood pressure and is associated with alterations in the gut microbiome and fecal metabolome in rats. Physiol Genomics. 2020 Jun;52(7):280–292. doi: 10.1152/physiolgenomics.00039.2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Bowers SJ, Vargas F, Gonzalez A, He S, Jiang P, Dorrestein PC, et al. Repeated sleep disruption in mice leads to persistent shifts in the fecal microbiome and metabolome. PLoS One. 2020 Feb;15(2):e0229001. doi: 10.1371/journal.pone.0229001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Triplett J, Ellis D, Braddock A, Roberts E, Ingram K, Perez E, et al. Temporal and region-specific effects of sleep fragmentation on gut microbiota and intestinal morphology in Sprague Dawley rats. Gut Microbes. 2020 Jun;11(4):706–720. doi: 10.1080/19490976.2019.1701352. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Anderson JR, Carroll I, Azcarate-Peril MA, Rochette AD, Heinberg LJ, Peat C, et al. A preliminary examination of gut microbiota, sleep, and cognitive flexibility in healthy older adults. Sleep Med. 2017 Oct;38:104–107. doi: 10.1016/j.sleep.2017.07.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Ma Q, Xing C, Long W, Wang HY, Liu Q, Wang RF. Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis. J Neuroinflammation. 2019 Mar;16(1):53–53. doi: 10.1186/s12974-019-1434-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Cryan JF, O’Riordan KJ, Cowan CSM, Sandhu K V, Bastiaanssen TFS, Boehme M, et al. The microbiota-gut-brain axis. Physiol Rev. 2019 Oct;99(4):1877–2013. doi: 10.1152/physrev.00018.2018. [DOI] [PubMed] [Google Scholar]
- 14.Schroeder BO, Backhed F. Signals from the gut microbiota to distant organs in physiology and disease. Nat Med. 2016 Oct;22(10):1079–1089. doi: 10.1038/nm.4185. [DOI] [PubMed] [Google Scholar]
- 15.Krueger JM, Opp MR. Sleep and microbes. Int Rev Neurobiol. 2016;131:207–225. doi: 10.1016/bs.irn.2016.07.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Poroyko VA, Carreras A, Khalyfa A, Khalyfa AA, Leone V, Peris E, et al. Chronic sleep disruption alters gut microbiota, induces systemic and adipose tissue inflammation and insulin resistance in mice. Sci Rep. 2016 Oct;6:35405–35405. doi: 10.1038/srep35405. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Zhang SL, Bai L, Goel N, Bailey A, Jang CJ, Bushman FD, et al. Human and rat gut microbiome composition is maintained following sleep restriction. Proc Natl Acad Sci U S A. 2017 Feb;114(8):1564–1571. doi: 10.1073/pnas.1620673114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. 2009 Nov;1(6) doi: 10.1126/scitranslmed.3000322. 6ra14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Collins J, Auchtung JM, Schaefer L, Eaton KA, Britton RA. Humanized microbiota mice as a model of recurrent Clostridium difficile disease. Microbiome. 2015 Aug;3:35–35. doi: 10.1186/s40168-015-0097-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Mooser C, Agüero MG, Ganal-Vonarburg SC. Standardization in host-microbiota interaction studies: challenges, gnotobiology as a tool, and perspective. Curr Opin Microbiol. 2018 Aug;44:50–60. doi: 10.1016/j.mib.2018.07.007. [DOI] [PubMed] [Google Scholar]
- 21.National Research Council (US) Guide for the care and use of laboratory animals. 8th. Washington, DC: National Academies Press; 2011. [Google Scholar]
- 22.Braddock A, Ellis D, Roberts E, Triplett J, Bevins J, Brown D, et al. Development of rat model (Rattus Norvegicus) harboring homogenous profile of human microbiota derived from multiple donors with diverse microbial populations. Biomed J Sci Tech Res. 2020;25(2):19006–19019. [Google Scholar]
- 23.Ramesh V, Kaushal N, Gozal D. Sleep fragmentation differentially modifies EEG delta power during slow wave sleep in socially isolated and paired mice. Sleep Sci. 2009;2(2):64–75. [Google Scholar]
- 24.Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010 May;7(5):335–336. doi: 10.1038/nmeth.f.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Amir A, McDonald D, Navas-Molina JA, Kopylova E, Morton JT, Xu ZZ, et al. Deblur rapidly resolves single-nucleotide community sequence patterns. mSystems. 2017 Apr;2(2):e00191-16. doi: 10.1128/mSystems.00191-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Cock PJA, Fields CJ, Goto N, Heuer ML, Rice PM. The Sanger FASTQ file format for sequences with quality scores, and the Solexa/Illumina FASTQ variants. Nucleic Acids Res. 2009 Apr;38(6):1767–1771. doi: 10.1093/nar/gkp1137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K, et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. 2006 Jun;72(7):5069–5072. doi: 10.1128/AEM.03006-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Faith D P, Baker AM. Phylogenetic diversity (PD) and biodiversity conservation: some bioinformatics challenges. Evol Bioinform Online. 2006 Feb;2:121–128. [PMC free article] [PubMed] [Google Scholar]
- 29.Lozupone CA, Hamady M, Kelley ST, Knight R. Quantitative and qualitative beta diversity measures leads to different insights into factors that structure microbial communities. Appl Environ Microbiol. 2007 Mar;73(5):1576–1585. doi: 10.1128/AEM.01996-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Vázquez-Baeza Y, Pirrung M, Gonzalez A, Knight R. EMPeror: a tool for visualizing high-throughput microbial community data. Gigascience. 2013 Nov;2(1):16–16. doi: 10.1186/2047-217X-2-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Morton JT, Sanders J, Quinn RA, McDonald D, Gonzalez A, Vázquez-Baeza Y, et al. Balance trees reveal microbial niche differentiation. mSystems. 2017 Jan/Feb;2(1):e00162-16. doi: 10.1128/mSystems.00162-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Douglas GM, Beiko RG, Langille MGI. Predicting the functional potential of the microbiome from marker genes using PICRUSt. Methods Mol Biol. 2018;1849:169–177. doi: 10.1007/978-1-4939-8728-3_11. [DOI] [PubMed] [Google Scholar]
- 33.Parks DH, Tyson G W, Hugenholtz P, Beiko RG. STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics. 2014 Nov;30(21):3123–3124. doi: 10.1093/bioinformatics/btu494. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Aidy SE, Van Den Bogert B, Kleerebezem M. The small intestine microbiota, nutritional modulation and relevance for health. Curr Opin Biotechnol. 2015 Apr;32:14–20. doi: 10.1016/j.copbio.2014.09.005. [DOI] [PubMed] [Google Scholar]
- 35.Hintze KJ, Cox JE, Rrompato G, Benninghoff AD, Ward R, Broadbent J, et al. Broad scope method for creating humanized animal models for animal health and disease research though antibiotic treatment and human fecal transfer. Gut Microbes. 2014 Mar/Apr;5(2):183–191. doi: 10.4161/gmic.28403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Staley C, Kaiser T, Beura LK, Hamilton MJ, Weingaden AR, Bobr A, et al. Stable engraftment of human microbiota into mice with a single oral gavage following antibiotic conditioning. Microbiome. 2017 Aug;5(1):87–87. doi: 10.1186/s40168-017-0306-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Wos-Oxley ML, Bleich A, Oxley APA, Kahl S, Janus LM, Smoczek A, et al. Comparative evaluation of establishing a human gut microbial community within rodent models. Gut Microbes. 2012 May/Jun;3(3):234–249. doi: 10.4161/gmic.19934. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Rizzatti G, Lopetuso LR, Gibiino G, Binda C, Gasbarrini A. Proteobacteria: a common factor in human diseases. Biomed Res Int. 2017;2017:9351507–9351507. doi: 10.1155/2017/9351507. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Selvanantham T, Lin Q, Guo CX, Surendra A, Fieve S, Escalante NK, et al. NKT cell-deficient mice harbor an altered microbiota that fuels intestinal inflammation during chemically induced colitis. J Immunol. 2016 Dec;197(11):4464–4472. doi: 10.4049/jimmunol.1601410. [DOI] [PubMed] [Google Scholar]
- 40.Carvalho FA, Koren O, Goodrich JK, Johansson MEV, Nalbantoglu I, Aitken JD, et al. Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. Cell Host Microbe. 2012 Aug;12(2):139–152. doi: 10.1016/j.chom.2012.07.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Ma W, Song J, Wang H, Shi F, Zhou N, Jiang J, et al. Chronic paradoxical sleep deprivation-induced depression-like behavior, energy metabolism and microbial changes in rats. Life Sci. 2019 May;225:88–97. doi: 10.1016/j.lfs.2019.04.006. [DOI] [PubMed] [Google Scholar]
- 42.Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. Nature. 2009 Jan;457(7228):480–484. doi: 10.1038/nature07540. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Horie M, Miura T, Hirakata S, Hosoyama A, Sugino S, Umeno A, et al. Comparative analysis of the intestinal fora in type 2 diabetes and nondiabetic mice. Exp Anim. 2017;66(4):405–416. doi: 10.1538/expanim.17-0021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Forbes JD, Van Domselaar G, Berstein CN. The gut microbiota in immune-mediated inflammatory diseases. Front Microbiol. 2016;7:1081–1081. doi: 10.3389/fmicb.2016.01081. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Labus JS, Hsiao E, Tap J, Derrien M, Gupta A, Le Nevé B, et al. Clostridia from the gut microbiome are associated with brain functional connectivity and evoked symptoms in IBS. Gastroenterology. 2017 Apr;152(5):S40–S40. [Google Scholar]
- 46.Labus JS, Osadchiy V, Hsiao E, Tap J, Derrien M, Gupta A, et al. Evidence for an association of gut microbial Clostridia with brain functional connectivity and gastrointestinal sensorimotor function in patients with irriTable bowel syndrome, based on tripartite network analysis. Microbiome. 2019 Mar;7(1):45–45. doi: 10.1186/s40168-019-0656-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Weis S, Schwiertz A, Unger MM, Becker A, Fabbender K, Ratering S, et al. Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota. NPJ Parkinsons Dis. 2019 Nov;5:28–28. doi: 10.1038/s41531-019-0100-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Nakanishi Y, Sato T, Ohteki T. Commensal gram-positive bacteria initiates colitis by inducing monocyte/macrophage mobilization. Mucosal Immunol. 2015 Jan;8(1):152–160. doi: 10.1038/mi.2014.53. [DOI] [PubMed] [Google Scholar]
- 49.Kameyama K, Itoh K. Intestinal colonization by a Lachnospiraceae bacterium contributes to the development of diabetes in obese mice. Microbes Environ. 2014;29(4):427–430. doi: 10.1264/jsme2.ME14054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Browner WS, Kahn AJ, Ziv E, Reiner A P, Oshima J, Cawthon RM, et al. The genetics of human longevity. Am J Med. 2004 Dec;117(11):851–860. doi: 10.1016/j.amjmed.2004.06.033. [DOI] [PubMed] [Google Scholar]
- 51.Okumura R, Takeda K. Roles of intestinal epithelial cells in the maintenance of gut homeostasis. Exp Mol Med. 2017 May;49(5):e338. doi: 10.1038/emm.2017.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Everson CA, Toth LA. Systemic bacterial invasion induced by sleep deprivation. Am J Physiol Integr Comp Physiol. 2017 Apr;278(4):R905–R916. doi: 10.1152/ajpregu.2000.278.4.R905. [DOI] [PubMed] [Google Scholar]
- 53.Santaolalla R, Abreu MT. Innate immunity in the small intestine. Curr Opin Gastroenterol. 2012 Mar;28(2):124–129. doi: 10.1097/MOG.0b013e3283506559. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Murakami T. Absorption sites of orally administered drugs in the small intestine. Expert Opin Drug Discov. 2017 Dec;12(12):1219–1232. doi: 10.1080/17460441.2017.1378176. [DOI] [PubMed] [Google Scholar]
- 55.Clevers H. The intestinal crypt, a prototype stem cell compartment. Cell. 2013 Jun;154(2):274–284. doi: 10.1016/j.cell.2013.07.004. [DOI] [PubMed] [Google Scholar]
